Switching is straightforward since both medications contain identical semaglutide molecules
What differentiates suppliers is the purity at the time of manufacturing (verified via Janoshik testing) and the shipping speed (how much time the peptide spends outside refrigeration)
All anti obesity medications including semaglutide, tirzepatide, and liraglutide, may carry gastrointestinal adverse events such as abdominal pain, decreased appetite, and nausea, and they should be used under close medical supervision, particularly in individuals with a family medical history of thyroid cancer, or existing cardiovascular disease, chronic kidney disease, or risk of heart attack
The goal is to flush bacteria from the urinary tract as aggressively as possible
This practice also carries risks such as loss of sterility and stability of the drug, which can compromise its safety and cause contamination